|
|
||||||||
Transgenic Mouse: Aberrantly Expressed IFN-
Enhances Hematopoietic Stem Cell Apoptosis and Affects NK Cell Differentiation1

*
Laboratory of Experimental Immunology, Center for Cancer Research, and
Intramural Research Support Program, Science Applications International Corp.-Frederick, National Cancer Institute, Frederick, MD 21702
Aberrant expression of IFN-
has been demonstrated to cause a
wide variety of alterations in cell function and development.
Previously we reported that constitutive expression of IFN-
in bone
marrow (BM) and thymus results in a total absence of B cells and a
substantial decrease in the number of hematopoietic progenitor cells.
In this study, we demonstrate a severe deficiency of
NK1.1+CD3- cells in this transgenic mouse
model. Compared with normal control littermates, we found a pronounced
reduction of NK cells in IFN-
transgenic mouse spleen and liver
despite maintenance of normal function. In addition, we observed a
reduced number of BM cells in the IFN-
transgenic mouse despite
normal expression of hematopoietic growth factors in the BM.
Interestingly, these cells were less responsive to stem cell factor
(SCF) despite c-kit expression on hematopoietic stem
cells (HSCs). We observed that addition of exogenous IFN-
inhibited
proliferation of HSCs and differentiation of NK precursors from HSCs in
normal mice in response to SCF, IL-7, fms-like tyrosine
kinase 3 ligand, and IL-15. Furthermore, we found that HSCs express the
IFN-
R
subunit and undergo apoptosis in response to exogenous
IFN-
. Thus, we have demonstrated the occurrence of a severe
deficiency of NK cells and lower numbers of BM cells in an IFN-
transgenic mouse model. Furthermore, because exogenous IFN-
affects
the responsiveness to hematopoietic growth factors such as SCF in
vitro, our results indicate that chronic expression of IFN-
in vivo
leads to widespread immune system defects, including alterations in NK
cell differentiation.
This article has been cited by other articles:
![]() |
K. Nakagome, K. Okunishi, M. Imamura, H. Harada, T. Matsumoto, R. Tanaka, J.-i. Miyazaki, K. Yamamoto, and M. Dohi IFN-{gamma} Attenuates Antigen-Induced Overall Immune Response in the Airway As a Th1-Type Immune Regulatory Cytokine J. Immunol., July 1, 2009; 183(1): 209 - 220. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Becknell, T. L. Hughes, A. G. Freud, B. W. Blaser, J. Yu, R. Trotta, H. C. Mao, M. L. Caligiuri de Jesus, M. Alghothani, D. M. Benson Jr, et al. Hlx homeobox transcription factor negatively regulates interferon-{gamma} production in monokine-activated natural killer cells Blood, March 15, 2007; 109(6): 2481 - 2487. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yu, G. C. Sharp, and H. Braley-Mullen Dual Roles for IFN-{gamma}, But Not for IL-4, in Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice J. Immunol., October 1, 2002; 169(7): 3999 - 4007. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |